C. Pérez‐Sánchez

Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα

Carmen Castro, C. Pérez‐Sánchez, Alejandro Escudero‐Contreras et al. · Arthritis Research & Therapy · 2015 · 164 citations · Full text

Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome

R. Teruel, C. Pérez‐Sánchez, Javier Corral et al. · Journal of Thrombosis and Haemostasis · 2011 · 119 citations · Full text

Inflammation, Autoimmune Disease, Systemic Lupus Erythematosus +13

Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in Rheumatoid Arthritis patients

C. Pérez‐Sánchez, Patricia Ruiz‐Limón, M. Á. Aguirre et al. · Journal of Autoimmunity · 2017 · 115 citations

Inflammation, Rheumatology, Rheumatoid Disorder +10

Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation

Patricia Ruiz‐Limón, Rafaela Ortega, I. Arias de la Rosa et al. · Translational research · 2016 · 103 citations

Inflammation, Rheumatology, Thrombosis +15

Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q10 treatment

C. Pérez‐Sánchez, Patricia Ruiz‐Limón, M. Á. Aguirre et al. · Blood · 2012 · 98 citations · Full text